Medicines

Quadrivalent flu jab launched

Sanofi Pasteur recently launched a quadrivalent influenza vaccine in the UK that protects against two A and two B strains

New antibiotic launched

Pfizer has launched Zavicefta (ceftazidime-avibactam) for adults hospitalised with serious infections

Verapamil for rhinosinusitis?

Verapamil dramatically improves symptom scores in patients with chronic rhinosinusitis and nasal polyps

NSAIDs and paracetamol linked to hearing loss

NSAIDs and paracetamol might increase the risk of hearing loss, according to an analysis of 55,850 women

Rotavirus vaccine is preventing gastroenteritis in infants

Infant rotavirus vaccine reduces the number of episodes of acute gastroenteritis by up to half and saves £12.5m a year

Teva launches reformulated levothyroxine range

Teva has launched a reformulated version of levothyroxine, including two previously unavailable strengths

Xultophy approved for renal impairment

Xultophy has been approved for adults with type 2 diabetes and moderate renal impairment

Update: media scare stories cutting statin use?

Media stories questioning the safety of statins are causing people to stop taking the drugs

Update: Enstilar – new psoriasis drug

Enstilar (calcipotriol and betamethasone dipropionate) is a new topical, alcohol-free, foam spray for plaque psoriasis

Massive increase in ADHD prescribing

Prescriptions for ADHD drugs in the UK increased by almost 800 per cent between 2000 and 2015

Benzodiazepines could significantly increase flu risk

Benzodiazepines may increase mortality more than 20-fold in people with influenza-like illness, new research finds

Actavis adds gliclazide 40mg

Actavis has added gliclazide 40mg tablets alongside the existing 80mg tablet offer

New ticagrelor dose

Marketing authorisation has been granted for a 60mg dose of ticagrelor for patients who have suffered a heart attack  

New lung cancer drug

The European Commission has granted marketing authorisation for necitumumab (Portrazza) for lung cancer

Ezetimibe indication widened

The MHRA recently extended the indication for ezetimibe (Ezetrol)

Dementia script numbers rise but costs fall

The number of prescriptions for drugs for Alzheimer’s disease rose more than six-fold over the past decade

GORD quality standards

NICE has published nine quality standards covering GORD in children and young people

Cyramza’s new cancer indications

The European Commission recently approved two new indications for ramucirumab (Cyramza)

Dispensary: Reltebon price cut

Actavis has reduced the list price of Reltebon (oxycodone hydrochloride) prolonged-release tablets

Entresto: a new heart failure drug

Entresto (sacubitril plus valsartan) is now available for adults with symptomatic chronic heart failure.
Previous 1 2 3 Next

Latest

Price concession delays added to contractor stress

Not all of the requested concession prices for the November dispensing month have been granted, says PSNC

Half of Brits take prescription drugs daily

Almost half of UK adults have taken at least one prescribed medicine in the last week, according to a new survey commiss...

Views

Flu jabs: let’s do a fantastic job

By NPA chief pharmacist Leyla Hannbeck. If Australia’s experience is anything to go by, we all need to be ready to dea...

Popular

NHS negligence bill quadruples in a decade

The Government must take steps to rein in the increasing cost of clinical negligence claims as numbers rocket, NAO warns

Alliance deliveries return to normal after IT problems

Alliance Healthcare has recovered services after significant IT problems affected the wholesaler last week

Pharmacy Magazine goes green for Pharmacist Support

Pharmacy Magazine goes green to mark the start of Pharmacist Support’s annual fundraising week